[ad_1] In a new badysis of the study "ODYSSEY Outcomes", patients with recent acute coronary syndrome (ACS) and diabetes have benefited the most in terms of adverse cardiac events (MACE) after treatment …
Read More »MACE reduced by alirocumab plus statin in diabetic patients and
